Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands

Rosa Conforti, Yuting Ma, Yannis Morel, Carine Paturel, Magali Terme, Sophie Viaud, Bernard Ryffel, Maria Ferrantini, Ravindra Uppaluri, Robert Schreiber, Christophe Combadière, Nathalie Chaput, Fabrice André, Guido Kroemer, Laurence Zitvogel

Open source

DOI
10.1158/0008-5472.can-09-1890
Published
2010-01-13
Container
Cancer Research
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-09-1890,
  title = {Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands},
  author = {Rosa Conforti and Yuting Ma and Yannis Morel and Carine Paturel and Magali Terme and Sophie Viaud and Bernard Ryffel and Maria Ferrantini and Ravindra Uppaluri and Robert Schreiber and Christophe Combadière and Nathalie Chaput and Fabrice André and Guido Kroemer and Laurence Zitvogel},
  year = {2010},
  journal = {Cancer Research},
  doi = {10.1158/0008-5472.can-09-1890},
  url = {https://doi.org/10.1158/0008-5472.can-09-1890}
}

RIS

TY  - JOUR
TI  - Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands
AU  - Rosa Conforti
AU  - Yuting Ma
AU  - Yannis Morel
AU  - Carine Paturel
AU  - Magali Terme
AU  - Sophie Viaud
AU  - Bernard Ryffel
AU  - Maria Ferrantini
AU  - Ravindra Uppaluri
AU  - Robert Schreiber
AU  - Christophe Combadière
AU  - Nathalie Chaput
AU  - Fabrice André
AU  - Guido Kroemer
AU  - Laurence Zitvogel
PY  - 2010
JO  - Cancer Research
DO  - 10.1158/0008-5472.can-09-1890
UR  - https://doi.org/10.1158/0008-5472.can-09-1890
ER  - 

APA

Conforti, R., Ma, Y., Morel, Y., Paturel, C., Terme, M., Viaud, S., Ryffel, B., Ferrantini, M., Uppaluri, R., Schreiber, R., Combadière, C., Chaput, N., André, F., Kroemer, G., & Zitvogel, L. (2010). Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands. Cancer Research. https://doi.org/10.1158/0008-5472.can-09-1890

Source records